OUR: Sacroiliac Joint Fixation
What it covers
sacroiliac joint fusion
FDA’s definition of product code OUR, from the Product Classification database.
FDA flags OUR devices as implants.
Recent clearances
| 510(k) | Device | Applicant | Decision | Type |
|---|---|---|---|---|
| K262522 | Odys-SI Screw | Medyssey Co, Ltd. | Oct 15, 2026 | Traditional |
| K261381 | TiLink-L SI Joint Fusion System | SurGenTec, LLC | Aug 24, 2026 | Traditional |
| K260477 | CATAMARAN SI Joint Fusion System | Tenon Medical | Apr 8, 2026 | Traditional |
| K253488 | iFuse INTRA Ti Implant System | SI-BONE, Inc. | Feb 11, 2026 | Traditional |
| K253611 | Falco Fusion System | Mcnicoll Surgical, Inc. | Jan 29, 2026 | Traditional |
| K252834 | Sacroiliac Joint Truss System (SJTS) | 4Web Medical | Jan 28, 2026 | Traditional |
| K251365 | OptumSI Implant System | Si Solutions, LLC | Nov 20, 2025 | Traditional |
| K252322 | SIros-X System | Genesys Spine | Oct 22, 2025 | Traditional |
| K253094 | iFuse Bedrock Granite Implant System | SI-BONE, Inc. | Oct 9, 2025 | Special |
| K250894 | Eminent Spine Posterior SI System | Eminent Spine | Oct 7, 2025 | Traditional |
Clearances by year
129 OUR 510(k)s were cleared from 2011 to Oct 29, 2026. Days to decision run from the day FDA received the 510(k) to its decision, including time on hold.
| Year | Clearances | Median days to decision |
|---|---|---|
| 2026 (so far) | 6 | 98 |
| 2025 | 14 | 97 |
| 2024 | 15 | 74 |
| 2023 | 20 | 55 |
| 2022 | 14 | 149 |
| 2021 | 9 | 85 |
| 2020 | 7 | 88 |
| 2019 | 7 | 89 |
| 2018 | 7 | 82 |
| 2017 | 4 | 120 |
| 2016 | 6 | 168 |
| 2015 | 8 | 111 |
| 2014 | 3 | 91 |
| 2013 | 4 | 103 |
| 2012 | 2 | 277 |
| 2011 | 3 | 27 |
Who submits
63 applicants cleared a OUR device since 2011. 91% of the clearances went to applicants in United States, then South Korea (5%), Switzerland (2%) and Canada (1%). By type: Traditional 72% and Special 28%.
| Applicant | Clearances since 2011 |
|---|---|
| SI-BONE, Inc. | 25 |
| SurGenTec, LLC | 7 |
| Life Spine, Inc. | 5 |
| Orthofix, Inc. | 5 |
| Zyga Technology, Inc. | 5 |
| L&K BIOMED Co., Ltd. | 4 |
| Cutting Edge Spine, LLC | 3 |
| Medacta International S.A. | 3 |
How FDA classifies it
Class II.
From 21 CFR 888.3040.
Standards
21 CFR 888.3040 names no consensus standards. Check FDA’s recognized standards database, or ask which standards recent OUR clearances declared.
Ask about OUR
Questions about OUR
What is FDA product code OUR?
Product code OUR, “Sacroiliac Joint Fixation” in FDA's classification database, is a Class II device type under 21 CFR 888.3040 (smooth or threaded metallic bone fixation fastener), reviewed by FDA's Orthopedic panel. FDA's 510(k) database lists 133 clearances under OUR, 129 of them since 2011.
How many 510(k) clearances are there under OUR?
FDA’s 510(k) database listed 133 clearances under OUR as of Oct 29, 2026, 129 of them decided since 2011; the most recent decision was Oct 15, 2026. The Predicate Finder searches the live database.
How long does FDA take to clear a OUR 510(k)?
For the 22 OUR clearances decided in the two years before Oct 29, 2026, the median time from FDA receiving the 510(k) to its decision was 95 days. That counts calendar days, including time the submission was on hold waiting for answers from the submitter.
Which companies have the most OUR clearances?
Since 2011: SI-BONE, Inc. (25), SurGenTec, LLC (7), Life Spine, Inc. (5), Orthofix, Inc. (5) and Zyga Technology, Inc. (5). 63 applicants have cleared a OUR device in that time.